CareDx Priced, Nasdaq: CDNA
Sells molecular diagnostic tests to monitor heart transplants.
Industry: Health Care
First Day Return: -9.5%
Industry: Health Care
CDNA
Sells molecular diagnostic tests to monitor heart transplants.
| IPO Data | |
|---|---|
| IPO File Date | 06/03/2014 |
| Offer Price | $10.00 |
| Price Range $15.00 - $17.00 | |
| Offer Shares (mm) | 4.0 |
| Deal Size ($mm) | $40 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 07/16/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $40 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Brisbane, CA, United States |
| Founded | 1998 |
| Employees at IPO | 55 |
| Website www.caredxinc.com | |
IPO News for CareDx
CareDx (CDNA) Performance
